|
Çѱ¹MSD À¯ÇÑȸ»ç |
Oncology MSL 2¸í ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
10.31 |
|
|
DOCS ICON Resourcing Solutions |
¿Ü±¹°è CRO-Study Authorization Associate (1¸í)
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
09.23 |
|
|
Çѱ¹¿¥¿¡½ºµð ÁÖ½Äȸ»ç |
[Çѱ¹MSD] MSL-ID/Vaccine
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
08.13 |
|
|
(ÁÖ)Áö¿À¿µ |
ÀǾàÇ°À¯Åë Ç°Áú°ü¸®¾à»ç ä¿ë
ÀÎõ ¼±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
05.10 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
[Çѱ¹MSD]RA Specialist ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
06.07 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
(Sr.)RA Specialist 2¸í ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
05.13 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Medcial Service Specialist ¸ðÁý
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
3³â¡è |
ä¿ë½Ã |
05.17 |
|
|
½«Ä¿ÄÚ¸®¾Æ |
Healthcare Quality Management(Pharmacist)
°æ±â ±ºÆ÷½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
3³â¡è |
ä¿ë½Ã |
05.20 |
|
|
½ÎÀÌÁ¨ÄÚ¸®¾Æ(ÁÖ) |
½ÎÀÌÁ¨ÄÚ¸®¾Æ(ÁÖ) ¼öÀÔ°ü¸® ¾à»ç(ÆÄÆ®) ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
3³â¡è |
ä¿ë½Ã |
03.03 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Market access(Price&reimburse)specialist ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
±¤°í/È«º¸/PR/»çº¸ |
3³â¡è |
ä¿ë½Ã |
10.29 |
|
|
(ÁÖ)ÄÚ¸®¾ÆÈÞ¸Õ¸®¼Ò½Ã½º |
¿Ü±¹°è ±â¾÷ RA Manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
5³â¡è |
ä¿ë½Ã |
09.19 |
|
|
µ¿±¹Á¦¾à(ÁÖ) |
Á¦Á¶°ü¸®ÀÚ(Ç°Áú) ¾à»ç ¸ðÁý(°æ·Â 5³â¡è)
ÃæºÏ Áøõ±º | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
5³â¡è |
ä¿ë½Ã |
04.11 |
|
|
ÄÚ¿À·ÕÁ¦¾à(ÁÖ) |
´ëÀü »ý»êÆÀÀå ¾à»ç ¸ðÁý(°æ·Â 5³â¡è)
´ëÀü ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
5³â¡è |
ä¿ë½Ã |
04.11 |
|
|
ÇÏÀÌÅÍÄ¡¹ø¿ª |
ÀǾàÇÐ Àü¹® ¹ø¿ª»ç(ÇÁ¸®·£¼)¸¦ ¸ðÁýÇÕ´Ï´Ù
Àü±¹ Àü±¹, ÇØ¿Ü ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
˂ȍ |
5³â¡è |
ä¿ë½Ã |
09.01 |
|
|
ÇÏÀÌÅÍÄ¡¹ø¿ª |
ÀǾàÇÐ Àü¹® ¹ø¿ª»ç(ÇÁ¸®·£¼)¸¦ ¸ðÁýÇÕ´Ï´Ù
Àü±¹ ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
5³â¡è |
ä¿ë½Ã |
08.24 |
|